Failure to inactivate CDK activity is responsible for the enhanced apoptotic response in U937 cells mediated by

Jinniu Deng1, Jianfeng Zhou, Fankai Meng

  • 1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030.

Insights

Silencing the ATM gene enhances apoptosis by maintaining active cyclin-dependent kinase (CDK) activity. This leads to increased cell death in response to irradiation and chemotherapy, highlighting CDK as a key molecular mechanism.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • The ATM gene plays a critical role in DNA damage response and cell cycle regulation.
  • ATM deficiency can lead to altered cellular responses to genotoxic stress, including apoptosis.
  • Understanding the molecular mechanisms underlying ATM-mediated apoptosis is crucial for cancer therapy.

Purpose of the Study:

  • To identify the molecular factors responsible for the enhanced apoptotic response in U937 cells with silenced ATM gene.
  • To investigate the role of cyclin-dependent kinase (CDK) activity and CDC25 proteins in ATM-deficient apoptosis.
  • To elucidate the signaling pathways linking ATM silencing to increased radiosensitivity and chemosensitivity.

Main Methods:

  • Utilized U937 cell mutants (ATM-negative and wild-type) as a model system.
  • Assessed apoptosis by measuring free nucleosome concentrations.
  • Employed Western blot to quantify specific protein levels (CDC25A, B, C; p34cdc2) and phosphorylation states.
  • Used RT-PCR to determine CDC25 transcript levels.

Main Results:

  • ATM-silenced cells (U937-ASPI3K) showed enhanced apoptosis upon irradiation, independent of protein synthesis.
  • Inhibition of protein phosphatases or CDK abolished this enhancement, indicating the involvement of phosphorylation/dephosphorylation and CDK activity.
  • Irradiation failed to inactivate p34cdc2 in ATM-silenced cells due to sustained nuclear CDC25 protein levels.
  • Active p34cdc2 and CDK2 were identified as key executors of apoptosis in the absence of ATM.

Conclusions:

  • Aberrantly activated CDK activity is the central molecular mechanism driving enhanced apoptosis in ATM-deficient cells.
  • Silencing the ATM gene prevents the inactivation of p34cdc2 after irradiation by maintaining CDC25 protein levels.
  • Active CDK activity acts as a critical executioner of apoptosis, contributing to increased sensitivity to irradiation and chemotherapy agents.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...